Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004326 · ClinicalTrials.gov registry record

Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome

A clinical trial, sponsored by National Center for Research Resources (NCRR).

Completed
Registry status
12
Enrollment target

NCT00004326 is a clinical trial that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004326 has completed, sponsored by National Center for Research Resources (NCRR).

COMPLETED
Registry status
12 participants
Enrollment target

Study Summary

OBJECTIVES: I. Evaluate whether chronic hypercortisolemia is specifically toxic to hippocampal cells and causes structural reduction of hippocampal volume in patients with Cushing's syndrome. II. Determine whether reduced hippocampal volume is associated with specific memory dysfunction. III. Examine the relationships of adrenal androgen to hippocampal volume and memory dysfunction. IV. Examine the reversibility of hippocampal structural changes and cognitive dysfunction after cortisol levels are normalized.

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 1994-08

What the Registry Record Tells You About NCT00004326

The ClinicalTrials.gov registry entry for NCT00004326 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00004326 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00004326 about?

NCT00004326 is a clinical study titled "Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome". OBJECTIVES: I. Evaluate whether chronic hypercortisolemia is specifically toxic to hippocampal cells and causes structural reduction of hippocampal volume in patients with Cushing's syndrome. II. Determine whether reduced hippocampal volume is associated with specific memory dysfunction. III. Exam...

What is the current status of trial NCT00004326?

This trial is currently completed. The enrollment target is 12 participants. The study started on 1994-08.

Who is sponsoring clinical trial NCT00004326?

This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.